Topics
- Conference(60)
- Covid(19)
- Exercise(4)
- Foot & Ankle(10)
- Gout(8)
- Hand(2)
- Hip(4)
- Hypermobility(11)
- Imaging(1)
- Injections(11)
- Knee(3)
- Osteoarthritis(8)
- Osteoporosis(11)
- Pain(18)
- Patient leaflets & Self Management(4)
- PCRMM webinars(24)
- Radiology(3)
- Red flags(11)
- Rheumatology(21)
- Shoulder and elbow(6)
- Spinal(11)
- Spondyloarthritis(5)
- Tendinopathy(3)
- Work and Training(27)
PCRMM Webinar: FCP Integration into the Workforce
Our first webinar, “FCP Implementation into the Workforce” took place on 28th January 2021 featuring 3 speakers – David Wilson, Simon Ingram and Abigail Henderson.
28 January 2021
Febuxostat
Febuxostat and allopurinol are urate-lowering therapies used to treat patients with gout. Following concerns about the cardiovascular safety of febuxostat, the European Medicines Agency recommended a post-licensing study assessing the […]
8 December 2020